CT‑based radiomics of bowel wall at baseline predicts the efficacy of Ustekinumab at week 16 in patients with Crohn's disease.
Saved in:
| Title: | CT‑based radiomics of bowel wall at baseline predicts the efficacy of Ustekinumab at week 16 in patients with Crohn's disease. |
|---|---|
| Authors: | Guo, Minyi1,2 (AUTHOR) guomy23@mail.sysu.edu.cn, Guan, Yilin1,2 (AUTHOR) guanylin@alumni.sysu.edu.cn, Hu, Siqi3 (AUTHOR) husq3@mail2.sysu.edu.cn, Zhang, Qi1 (AUTHOR) zhangq233@mail2.sysu.edu.cn, Lin, Jue2,4 (AUTHOR) Linj277@mail2.sysu.edu.cn, Xu, Zhaoyuan2,4 (AUTHOR) xuzhy57@mail2.sysu.edu.cn, Wu, Huibo2,4 (AUTHOR) wuhb6@mail2.sysu.edu.cn, Zhi, Min2,4 (AUTHOR) zhimin@mail.sysu.edu.cn, Yao, Jiayin2,4 (AUTHOR) yjyin@mail2.sysu.edu.cn, Zhong, Yingkui5 (AUTHOR) zhongyk3@mail2.sysu.edu.cn |
| Source: | Abdominal Radiology. Jun2026, Vol. 51 Issue 6, p2764-2775. 12p. |
| Database: | Academic Search Ultimate |
| ISSN: | 2366004X |
|---|---|
| DOI: | 10.1007/s00261-025-05247-6 |
